Who Paid My Doc
Novoeight
Drug Hemophilia
NDC 0169-7825-01
General payments
$153,069
Research payments
$147,202
Through program year 2025, $153,069 in general payments and $147,202 in research payments were reported against Novoeight (Hemophilia).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $16,725 | 27 |
| 2024 | General | $5,517 | 82 |
| 2023 | General | $3,182 | 138 |
| 2022 | General | $12,650 | 94 |
| 2021 | General | $10,632 | 94 |
| 2021 | Research | $1,000 | 1 |
| 2019 | General | $104,363 | 308 |
| 2019 | Research | $146,202 | 27 |
Breakdown
The top 5 of 22 recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
743 general · 28 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.